Centene Agrees to $215 Million Settlement With California for Alleged Medicaid Overbilling
The nation’s largest Medicaid insurer denies wrongdoing after the California attorney general’s office investigated it for inflating prescription drug costs.
Health Industry
1,121-1,140 of 4,021 results
-
-
‘We Ain’t Gonna Get It’: Why Bernie Sanders Says His ‘Medicare for All’ Dream Must Wait
As he takes the reins of the Senate Health, Education, Labor & Pensions Committee, the independent from Vermont and implacable champion of “Medicare for All” maps out his strategy for negotiating with Republicans — and Big Pharma.
By Arthur Allen -
Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients
Pharmacy closures by two of the biggest home infusion companies point to grave shortages and dangers for patients who require IV nutrition to survive.
By Arthur Allen -
A Technicality Could Keep RSV Shots From Kids in Need
The Vaccines for Children program, which buys more than half the pediatric vaccines in the U.S., may not cover the RSV shot for babies because it’s not technically a vaccine.
By Arthur Allen -
As Pandemic-Era Medicaid Provisions Lapse, Millions Approach a Coverage Cliff
States are trying to reach millions of Medicaid enrollees to make sure those still eligible remain covered and help others find new health insurance.
-
Nursing Home Owners Drained Cash During Pandemic While Residents Deteriorated
As the federal government debates whether to require higher staffing levels at nursing homes, financial records show owners routinely push profits to sister companies while residents are neglected. “A dog would get better care than he did,” one resident’s wife said.
By Jordan Rau -
Some Addiction Treatment Centers Turn Big Profits by Scaling Back Care
Private equity groups are cashing in on rising rates of alcohol and drug addiction in the U.S. But they aren’t necessarily investing in centers with the best treatment standards, and they often cut extra services.
-
Government Lets Health Plans That Ripped Off Medicare Keep the Money
In a surprise decision, U.S. officials yield to insurance industry demands — at least for now.
By Fred Schulte -
Montana Pharmacists May Get More Power to Prescribe
Supporters of a proposed law say it would fill a health provider gap in rural areas, while doctors worry it will give pharmacists power outside the scope of their education.
By Keely Larson -
As States Seek to Limit Abortions, Montana Wants to Redefine What Is Medically Necessary
Montana officials are looking to tighten rules around medically necessary abortions for those who use Medicaid as their health insurance. Reproductive health advocates and Democratic lawmakers have said the move is part of a broader agenda to whittle away access to the procedure.
-
Luring Out-of-State Professionals Is Just the First Step in Solving Montana’s Health Worker Shortage
Two proposals would make it easier for professionals with out-of-state licenses to work in Montana, but that tactic likely won’t be enough to fill the demand for mental health providers.
By Keely Larson As US Bumps Against Debt Ceiling, Medicare Becomes a Bargaining Chip
Episode 280The debt ceiling crisis facing Washington puts Medicare and other popular entitlement programs squarely on the negotiating table this year as newly empowered Republicans demand spending cuts. Meanwhile, as more Americans than ever have health insurance, the nation’s health care workforce is straining under the load. Joanne Kenen of the Johns Hopkins Bloomberg School of Public Health and Politico, Tami Luhby of CNN, and Victoria Knight of Axios join KHN’s chief Washington correspondent Julie Rovner to discuss these topics and more. Plus, for extra credit, the panelists recommend their favorite health policy stories of the week they think you should read, too.
-
A $30 Million Gift to Build an Addiction Treatment Center. Then Staffers Had to Run It.
Howard Buffett, son of billionaire investor Warren Buffett and chairman of his own charitable foundation, gave $30 million to build an addiction treatment center in the central Illinois community where he farms. But the money was a one-time gift for infrastructure, so the clinic is on its own to keep it running.
-
Readers and Tweeters Diagnose Greed and Chronic Pain Within US Health Care System
KHN gives readers a chance to comment on a recent batch of stories.
-
Postcard From San Francisco
The Biggest, Buzziest Conference for Health Care Investors Convenes Amid Fears the Bubble Will Burst
This year’s JPMorgan confab, the first since covid’s chilling effect on such gatherings, was full of energy and enthusiasm. But it was also marked by questions about the future of health care investment.
By Darius Tahir -
Will Your Smartphone Be the Next Doctor’s Office?
Entrepreneurs see smartphones as an opportunity to meet patients where they are. But many app-based diagnostic tools still need clinical validation to get buy-in from health care providers.
-
Despite Doctors’ Concerns, University of California Renews Ties With Religious Affiliates
The public university’s health system is renewing contracts with outside hospitals and clinics even as some doctors and faculty say clearer language is needed to protect physicians performing abortions and gender-affirming treatments.
-
Listen: Who Investigates Suspicious Deaths in Your Community — And Why It Matters
KHN senior correspondent Samantha Young appeared on the “Apple News Today” podcast and KOA, a public radio station in Denver, to discuss the difference between coroners and medical examiners and why it matters.
-
Hospitals’ Use of Volunteer Staff Runs Risk of Skirting Labor Laws, Experts Say
Hospitals using volunteers is commonplace. But some labor experts argue that deploying unpaid workers to do work that benefits the organization’s bottom line lets for-profit hospitals skirt federal labor laws, deprives employees of work, and potentially exploits the volunteers.
-
Behavioral Telehealth Loses Momentum Without a Regulatory Boost
As flexible treatment options spurred by the covid pandemic wane, patients relying on medications classified as controlled substances worry that without action to extend the loosened rules, it’ll be harder to get their meds.
By Darius Tahir